Hubei Jumpcan Pharmaceutical Co. Ltd. A | Ownership
Companies that own Hubei Jumpcan Pharmaceutical Co. Ltd. A
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
10,215,410
1.26%
-113,037
1.63%
12/31/2017
Penghua Fund Management Co., Ltd.
9,251,159
1.13%
3,226,700
0.57%
12/31/2017
Essence Fund Co., Ltd.
8,133,462
1%
3,877,948
2.16%
12/31/2017
Xingzheng Securities Asset Management Ltd.
4,616,467
0.56%
4,616,467
3.01%
03/31/2018
Minsheng Royal Fund Management Co., Ltd.
4,114,449
0.51%
1,442,236
1.59%
12/31/2017
China Merchants Fund Management Co., Ltd.
3,933,133
0.49%
712,965
0.57%
12/31/2017
Everbright Pramerica Fund Management Co., Ltd.
3,926,581
0.49%
3,716,095
1.13%
12/31/2017
Huatai-PineBridge Fund Management Co., Ltd.
2,121,978
0.26%
-1,044,938
0.27%
12/31/2017
Hongde Fund Management Co., Ltd.
2,092,975
0.26%
347,478
1.34%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
1,979,078
0.24%
1,967,578
1.37%
12/31/2017
| Address |
Baota Bay
Taizhou Jiangsu 225441
China
|
|
Employees
|
- |
| Website |
- |
| Updated |
07/08/2019 |
| Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the drug research and development, production, and sale. Its product covers pediatrics, breathing, and digestion field. Its product focuses on anti-inflammatory oral solution, enteric-coated capsules, and children fever particles. |
